Article: RxPedite has signed an agreement with Romark Pharmaceuticals to expand and enhance the company's commercialization efforts in support of Alinia for Oral Suspension, a prescription drug for diarrhea caused by giardia and cryptosporidium in children one through 11 years of age.(Account Wins)(Brief Article)

RxPedite has signed an agreement with Romark Pharmaceuticals to expand and enhance the company's commercialization efforts in support of Alinia for Oral Suspension, a prescription drug for diarrhea caused by giardia and cryptosporidium in children one through 11 years of age. RxPedite will support Romark in the development and ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!